To Be Discontinued Tablet Analgesia/Addiction
Oxaprozin Tablet · 431 days since initial FDA posting
Brand: DAYPRO
FDA lists Oxaprozin Tablet as To Be Discontinued (Hospira, Inc., a Pfizer Company).
No availability text on this FDA row.
Oxaprozin Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Oxaprozin Tablet
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Tablet
- Presentation
- Daypro, Tablet, 600 mg (NDC 0025-1381-31)
- Package NDC
- 0025-1381-31
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jul 17, 2025
- Last Updated
- Jul 17, 2025
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug.
Full Drug Profile
oxaprozin
Side effects, interactions, warnings & more
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.